PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |
PERSONAL CFO SOLUTIONS, LLC | 350,342 | $2,151,100 | 0.42% |
PFM Health Sciences, LP | 1,295,104 | $7,951,939 | 0.38% |
SECTORAL ASSET MANAGEMENT INC | 303,824 | $1,865,479 | 0.36% |
RTW INVESTMENTS, LP | 2,375,785 | $14,587,320 | 0.31% |
Avoro Capital Advisors LLC | 3,000,000 | $18,420,000 | 0.29% |
Verition Fund Management LLC | 2,466,388 | $15,143,622 | 0.18% |
Woodline Partners LP | 1,090,740 | $6,697,144 | 0.08% |
DENALI ADVISORS LLC | 30,500 | $187,270 | 0.07% |
Virtus ETF Advisers LLC | 16,534 | $101,519 | 0.06% |
MOORE CAPITAL MANAGEMENT, LP | 305,200 | $1,873,928 | 0.04% |
External links
This page lists PMV PHARMACEUTICALS INC's shareholders in Q3 2023. To view PMV PHARMACEUTICALS INC's shareholder history, click here.